VEGFA and macular retinal edema: Procedures required during the follow-up period included additional laser in three eyes (8.3%), in two eyes for progressive neovascularization and in one eye for macular edema, anti-VEGF with bevacizumab for macular edema in one eye, and re-operation with PPV with laser and no tamponade for rebleeding in three eyes (8.3%).